Filing Details
Allarity Therapeutics, Inc. (NASDAQ:ALLR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:ALLR
Allarity Therapeutics, Inc. (ALLR) Files Quarterly Report for Q0
Allarity Therapeutics, Inc. (NASDAQ:ALLR) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 14, 2026.
At publication ·
What changed
Allarity Therapeutics, Inc. (NASDAQ:ALLR) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Allarity Therapeutics filed its Q0 2026 quarterly report (Form 10-Q) on August 14, 2026 with the SEC.
- The company's stock trades at $1.37 per share with a market capitalization of $15.6 million.
- The quarterly report includes unaudited financial statements and management commentary on business performance, though specific revenue figures were not disclosed in this summary.
Market Context
Allarity Therapeutics, Inc.'s stock currently trades at $1.37 with a market capitalization of $15.6M.
The 10-Q provides Allarity Therapeutics, Inc.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for Allarity Therapeutics, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ALLR Stock Page
Frequently Asked Questions
Where can I read ALLR's SEC filings?
Browse all filings on our ALLR SEC filings page.
What types of SEC filings does Allarity Therapeutics, Inc. file?
Public companies like Allarity Therapeutics, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.